Literature DB >> 10754359

Inflammatory bowel disease and pregnancy: a review.

E S Jospe1, M A Peppercorn.   

Abstract

Inflammatory bowel disease often occurs during peak reproductive years. Rates of conception, pregnancy outcome and disease course during pregnancy should be discussed prior to attempted conception. The majority of patients whose disease is well controlled prior to pregnancy should expect a fertility rate comparable to the general population, and an uncomplicated pregnancy with a favorable outcome. The disease should continue to be pharmacologically or surgically controlled as necesssary during pregnancy; the majority of drug options available to pregnant patients being without detriment to the fetus. No predictable inheritance pattern has been established and, at this time, there is no ability to screen prenatally.

Entities:  

Mesh:

Year:  1999        PMID: 10754359     DOI: 10.1159/000016937

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  2 in total

1.  Risk of Adverse Pregnancy Outcomes for Women with IBD in an Expert IBD Antenatal Clinic.

Authors:  Gillian Lever; Hlupekile Chipeta; Tracey Glanville; Christian Selinger
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

2.  Is infliximab safe to use while breastfeeding?

Authors:  Joel-Z Stengel; Hays-L Arnold
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.